Articles

  • 2 weeks ago | ajmc.com | Laura Joszt |Hayden E. Klein |Mansi Shah

    While chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies, and other novel therapies are transforming multiple myeloma treatment, stem cell transplant remains a cost-effective and widely accessible first-line option, according to Mansi Shah, MD, clinical director of multiple myeloma at Rutgers Cancer Institute.

  • Feb 14, 2025 | cancernetwork.com | Cristina Gasparetto |Amandeep Godara |Ken Shain |Mansi Shah

    February 14, 2025By Panelists discuss how frailty assessment influences treatment decisions in patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM), particularly examining the IFM2017-03 study’s evaluation of a dexamethasone-sparing approach using daratumumab plus lenalidomide in frail patients. Video content above is prompted by the following:How does frailty impact treatment outcomes in transplant-ineligible NDMM?

  • Feb 14, 2025 | cancernetwork.com | Cristina Gasparetto |Amandeep Godara |Ken Shain |Mansi Shah

    February 14, 2025By Panelists discuss how the treatment landscape for patients with transplant-ineligible/deferred newly diagnosed multiple myeloma (NDMM) is expected to evolve, with considerations for optimizing therapeutic approaches based on emerging data from novel drug combinations and treatment strategies. Video content above is prompted by the following:How do you see the future treatment landscape for patients with transplant-ineligible/deferred NDMM? Related Content Related Content

  • Jan 28, 2025 | onclive.com | Mansi Shah

    CommentaryVideoJanuary 28, 2025Author(s):Mansi R. Shah, MD, highlights the data on the effects of IVIG on infections in patients with relapsed/refractory multiple myeloma treated with teclistamab. “When we looked overall, the risk of developing infections was significantly lower in the IVIG group with primary prophylaxis, particularly bacterial infections, but it didn't really have as much of an impact on viral infections.”Mansi R.

  • Jan 10, 2025 | hindustantimes.com | Mansi Shah

    Colleagues are turning into travel buddies. No, we’re not talking about the office trip.